Bisoprolol in pharma franchise in Karnataka

Bisoprolol in PCD pharma franchise in Gangtok

Bisoprolol in top pharma company in Chandigarh

Bisoprolol pcd pharma supplier in Raipur

Bisoprolol in phama franchise company in india
Bisoprolol phama distributor in Patna

Home/Products /bisoprolol-1-point-25-mg-tablet

Bisopair 1.25 Tablet

Composition : Bisoprolol 1.25 MG Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Bisopair 1.25 Tablet contains Bisoprolol (1.25 mg), a beta-blocker used for the management of hypertension (high blood pressure) and certain heart conditions. It helps in reducing the workload on the heart by slowing the heart rate and relaxing blood vessels, thereby improving blood circulation and lowering blood pressure.

Bisoprolol is widely prescribed for patients with mild to moderate hypertension, heart failure, and angina (chest pain). By blocking the effects of stress hormones like adrenaline, it ensures a steady heart rhythm and prevents excessive strain on the cardiovascular system. Additionally, Bisopair 1.25 Tablet helps in reducing the risk of future heart complications, such as heart attacks and strokes.

This medication is particularly beneficial for individuals with chronic heart conditions, as it enhances heart efficiency and prevents further deterioration. It is also useful in patients with stable chronic heart failure, improving symptoms and overall quality of life.

Bisopair 1.25 Tablet is well-tolerated when taken as prescribed. It is recommended to take this medication at the same time each day for optimal results. Dosage adjustments may be required for patients with kidney or liver issues, and it should always be used under medical supervision.

Read More

About the Product

Bisopair 1.25 Tablet contains Bisoprolol (1.25 mg), a beta-blocker used for the management of hypertension (high blood pressure) and certain heart conditions. It helps in reducing the workload on the heart by slowing the heart rate and relaxing blood vessels, thereby improving blood circulation and lowering blood pressure.

Bisoprolol is widely prescribed for patients with mild to moderate hypertension, heart failure, and angina (chest pain). By blocking the effects of stress hormones like adrenaline, it ensures a steady heart rhythm and prevents excessive strain on the cardiovascular system. Additionally, Bisopair 1.25 Tablet helps in reducing the risk of future heart complications, such as heart attacks and strokes.

This medication is particularly beneficial for individuals with chronic heart conditions, as it enhances heart efficiency and prevents further deterioration. It is also useful in patients with stable chronic heart failure, improving symptoms and overall quality of life.

Bisopair 1.25 Tablet is well-tolerated when taken as prescribed. It is recommended to take this medication at the same time each day for optimal results. Dosage adjustments may be required for patients with kidney or liver issues, and it should always be used under medical supervision.

Common side effects include fatigue, dizziness, headache, slow heart rate, cold hands and feet, and mild nausea. In rare cases, it may cause low blood pressure, breathing difficulties, or severe allergic reactions.

Used for the treatment of high blood pressure, heart failure, and angina (chest pain).

Should be taken under medical supervision. Not suitable for patients with severe heart block, bradycardia (slow heart rate), or severe asthma. Avoid sudden discontinuation, as it may cause rebound hypertension or heart-related issues.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation